The Latest Cardiac and Vascular News
BOSTON, Sept. 26, 2023 /PRNewswire/ — CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced that data from clinical studies examining the use of its eShunt System to treat elderly patients with normal pressure hydrocephalus and patients with communicating hydrocephalus following treatment for a ruptured cerebral aneurysm, was […]
ALISO VIEJO, Calif.–(BUSINESS WIRE)–MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced that the SOFIA™ EX 5F 115 cm Intracranial Support Catheter (Soft TOrqueable catheter For Intracranial Access) has received FDA 510(k) clearance on September 15, 2023, for transradial access in addition to transfemoral access. The unique […]
BOSTON, Sept. 18, 2023 /PRNewswire/ — CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) supplement to permit the expansion of the study of the eShunt System in patients with Normal Pressure […]
NEW YORK–(BUSINESS WIRE)–Synchron, the endovascular brain-computer interface (BCI) company developing technology to restore functionality in patients with severe paralysis, today announced completion of patient enrollment in the US-based COMMAND trial. “We look forward to announcing the results from our COMMAND study and will continue to advance development of Synchron Switch […]
YOKNEAM, Israel & MIAMI–(BUSINESS WIRE)–Rapid Medical™, a leading developer of advanced neurovascular devices, announced Chinese approval for its TIGERTRIEVER revascularization device. With this milestone of National Medical Product Administration (NMPA) approval, TIGERTRIEVER becomes the first device to offer patient-specific solutions for removing blood clots from the brain to advance the treatment of ischemic […]
PARIS–(BUSINESS WIRE)–Acticor Biotech, (ISIN: FR0014005OJ5 – ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies, announced today the results of its collaboration with Brainomix Limited, to further explore the imaging data using Artificial Intelligence (AI) from its phase 1b/2a ACTIMIS study. The ACTIMIS […]
KYOTO, Japan, Aug. 29, 2023 /PRNewswire/ — OMRON Healthcare Co., Ltd. (hereinafter referred to as the Company) based in Muko, Kyoto Prefecture, has announced the official sponsorship of the first annual meeting of the AF Screen International Collaboration, a collaborative group that was established to promote discussion and research about screening for unknown […]
JLK (www.jlkgroup.com), the leading healthcare AI firm, is poised to make significant inroads into the US market with its groundbreaking healthcare technology with AI for stroke. JLK is the leading company with the world’s largest pool of 11 stroke solutions, including both ischemic and hemorrhagic strokes. In addition, JLK has […]
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced that new data from studies evaluating the Zoom Stroke Solution were presented at the Society of NeuroInterventional Surgery (SNIS) 2023 20th Annual Meeting in San […]
SAN DIEGO & ALISO VIEJO, Calif.–(BUSINESS WIRE)–MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, announced the publication of WEB-IT 5-year follow-up data and the addition of two sizes to its WEB Aneurysm Embolization System. With this five-year clinical trial data just recently published, WEB is the most well […]
